Non-sympathetically maintained pain syndromes

1. High-Yield Summary

Non-sympathetically maintained pain syndromes, clinically designated as Sympathetically Independent Pain (SIP), represent chronic neuropathic disorders wherein pain generation and sensory aberrations are driven by autonomous peripheral and central neural mechanisms rather than efferent sympathetic adrenergic outflow. Clinicians must recognize these foundational tenets:

• Autonomic Independence: Unlike sympathetically maintained pain (SMP), SIP demonstrates zero to minimal (<30%) relief following diagnostic sympathetic blockade (stellate ganglion or lumbar sympathetic block) or systemic alpha-adrenergic antagonism with intravenous phentolamine.
• Primary Pathomechanisms: Pain generation is driven by ectopic pacemaker activity in injured primary afferents (voltage-gated sodium channel Nav1.7, Nav1.8, and Nav1.9 upregulation), dorsal horn central sensitization, and structural A-beta tactile fiber sprouting into superficial lamina II.
• Diagnostic Cardinal Rules: Successful diagnostic local anesthetic infiltration directly around a focal peripheral neuroma or entrapped nerve trunk abolishes >80% of pain, identifying an anatomically treatable peripheral generator.
• Surgical Reconstruction: Contemporary surgical treatment rejects simple traction neurectomy in favor of physiologic terminal axonal termination using Targeted Muscle Reinnervation (TMR) or Regenerative Peripheral Nerve Interfaces (RPNI).
• Absolute Contraindication: Surgical or chemical neurolytic sympathectomy is strictly contraindicated in confirmed SIP, as it provides zero analgesic efficacy while imposing severe morbidities, including Horner syndrome, neuralgia, and compensatory hyperhidrosis.

2. Anatomy

Understanding the anatomical boundaries and neural architecture of sympathetically independent pain requires distinguishing somatic primary afferent pathways from autonomic efferent chains, as well as mapping high-risk surgical corridors.

Primary Afferent Architecture & Spinal Cytoarchitecture

Sensory transduction from the extremities travels along pseudo-unipolar primary afferent neurons whose cell bodies reside within the dorsal root ganglion (DRG):

• Unmyelinated C-fibers: Slowly conducting (0.5 to 2.0 m/s) nociceptive fibers that terminate predominantly in Rexed lamina I (marginal zone) and outer lamina II (substantia gelatinosa) of the spinal cord dorsal horn.
• Thinly Myelinated A-delta fibers: Moderately conducting (5 to 30 m/s) mechanosensitive and thermosensitive nociceptive fibers terminating in laminae I and V.
• Large Myelinated A-beta fibers: Rapidly conducting (30 to 70 m/s) non-nociceptive low-threshold mechanoreceptors that terminate deeply in Rexed laminae III, IV, and V. Under persistent peripheral injury, structural trans-synaptic remodeling causes A-beta terminals to sprout aberrantly upward into lamina II, producing tactile allodynia.
• Sympathetic Efferent Pathways: Pre-ganglionic sympathetic cell bodies originate in the intermediolateral (IML) cell column of the thoracolumbar spinal cord (T1 to L2). Axons traverse the ventral roots and white rami communicantes to synapse in the paravertebral sympathetic ganglionic chain. Postganglionic unmyelinated fibers rejoin peripheral somatic nerves via gray rami communicantes. In SIP, somatic nociceptors lack functional coupling with these sympathetic efferents.

Neurovascular Danger Zones & Surgical Internervous Planes

Surgical exploration and neuroma reconstruction require meticulous exposure along validated anatomical planes to prevent iatrogenic deafferentation:

• Upper Extremity Anterior Forearm: The Henry approach utilizes the internervous plane between the brachioradialis (radial nerve) and the pronator teres / flexor carpi radialis (median nerve). Danger zones include the radial artery and the sensory branch of the radial nerve (SBRN).
• Medial Elbow & Cubital Tunnel: Exposure of the ulnar nerve traverses the subcutaneous plane anterior and posterior to the medial epicondyle. Danger zones include the branching arborization of the medial antebrachial cutaneous nerve (MACN), where iatrogenic transection causes excruciating neuromas on the resting surface of the elbow.
• Carpal Tunnel & Thenar Eminence: Decompression requires longitudinal incision aligned with the radial border of the ring finger. Danger zones include the palmar cutaneous branch of the median nerve (PCBMN, arborizing 5 cm proximal to the wrist crease) and the recurrent motor branch of the median nerve.
• Lower Extremity Fibular Neck & Peroneal Tunnel: Exploration of the common peroneal nerve requires dissection along the posterior border of the biceps femoris. Danger zones include the lateral sural cutaneous nerve and the deep/superficial peroneal bifurcation within the fibular tunnel.

3. Pathogenesis

The pathophysiology of sympathetically independent pain is governed by distinct peripheral neurobiological derangements and secondary spinal dorsal horn neuroplasticity that function independently of autonomic sympathetic regulation.

Peripheral Ectopic Pacemaker Generation & Channelopathy

Mechanical trauma, transection, or chronic entrapment interrupts retrograde axonal transport of essential target-derived neurotrophic factors, including nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF). This disruption triggers Wallerian degeneration distally and induces profound phenotypic alterations within the DRG and the regenerating nerve sprout:

• Sodium Channel Upregulation: Voltage-gated sodium channels (notably Nav1.3, Nav1.7, Nav1.8, and Nav1.9) accumulate in dense clusters along unmyelinated axonal sprouts, end-bulb neuromas, and demyelinated segments. This markedly reduces the threshold for action potential generation.
• Subthreshold Oscillations: Upregulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) pacemaker channels drives spontaneous rhythmogenesis and ectopic burst discharges without external mechanical or thermal stimulation.
• Mechanosensitivity: Sprouting axonal membranes express mechanosensitive ion channels (PIEZO2 and TRPA1/TRPV1), rendering the injured nerve exquisitely sensitive to light percussion, traction, and local tissue motion (positive Tinel sign).

Lack of Sympathetic-Sensory Coupling (Autonomic Independence)

In sympathetically maintained pain (SMP), primary nociceptive neurons pathologically express functional alpha-1 and alpha-2 adrenoceptors, allowing norepinephrine released from sympathetic varicosities or circulating catecholamines to trigger action potentials. In pure sympathetically independent pain (SIP), this neuro-sympathetic coupling does not develop or remains functionally silent. Consequently, chemical or surgical sympathetic denervation does not alter the frequency or amplitude of primary afferent firing.

Central Sensitization & Disinhibition in the Dorsal Horn

Unrelenting ectopic nociceptive input from the peripheral generator triggers profound maladaptive neuroplasticity within the spinal cord dorsal horn:

• NMDA Receptor Activation & Wind-Up: Continuous release of glutamate and neuropeptides (substance P, CGRP) removes the voltage-dependent magnesium (Mg²⁺) block from post-synaptic N-methyl-D-aspartate (NMDA) receptors. This causes massive intracellular calcium influx, activating protein kinase C (PKC) and MAP kinases, amplifying second-order neuron excitability.
• GABAergic and Glycinergic Disinhibition: Activated spinal microglial cells release brain-derived neurotrophic factor (BDNF). BDNF binds to TrkB receptors on dorsal horn lamina I neurons, downregulating the potassium-chloride cotransporter KCC2. The resulting intracellular chloride accumulation depolarizes the reversal potential of chloride, transforming normally inhibitory GABA and glycine transmission into paradoxically excitatory signaling.
• Phenotypic A-Beta Sprouting: Deafferentation of lamina II neurons stimulates large myelinated A-beta tactile fibers from laminae III/IV to sprout axon collaterals into superficial pain laminae. Light mechanical touch on non-injured skin is subsequently perceived as agonizing burning pain (dynamic mechanical allodynia).

4. Natural History

The clinical trajectory of sympathetically independent neuropathic pain depends on early identification of the peripheral pain generator versus consolidation of refractory central sensitization.

• Epidemiology: Sympathetically independent pain syndromes represent the overwhelming majority (>75% to 85%) of chronic post-traumatic and postsurgical neuropathic pain cases. Predominant clinical cohorts include amputees (residual limb neuroma and phantom pain), patients following extremity trauma with untreated nerve laceration or traction, and patients with chronic entrapment neuropathies.
• Disease Timeline: Following nerve injury or amputation, ectopic neuroma firing begins within 48 to 72 hours and peaks between 3 weeks and 6 months. When mechanical irritation persists, central sensitization becomes progressively autonomous. In patients with initial mixed pain (SMP and SIP components), the sympathetic component often fades over 12 to 24 months, leaving a fixed, refractory SIP state.
• Prognosis: Spontaneous resolution of symptomatic terminal neuromas or chronic compressive entrapment with central sensitization is exceedingly rare (<10%). Without definitive surgical or interventional intervention, patients experience secondary musculoskeletal sequelae, including joint contractures, limb disuse osteopenia, localized muscle atrophy, severe sleep disruption, and chronic psychological morbidity.

5. Clinical Presentation

Accurate clinical diagnosis requires a rigorous history focused on neuropathic descriptors, meticulous mapping of sensory deficits, and targeted provocative examination maneuvers.

Patient History

Clinicians should screen for characteristic features distinguishing SIP from sympathetically maintained pain and somatic musculoskeletal pain:

• Pain Descriptors: Persistent burning, raw, or freezing sensation punctuated by paroxysmal lancinating, shooting, or electric shock-like jabs.
• Mechanical Provocation: Intolerance to light touch from clothing, bed sheets, or gentle airflow (allodynia). Severe localized pain upon tapping or bumping a specific focal point along a surgical scar or amputation stump.
• Absence of Autonomic Instability: Unlike classic acute CRPS / SMP, patients with pure SIP typically lack profound dynamic temperature fluctuations (dramatic alternating hot/cold limb cycles), profuse asymmetric hyperhidrosis, or rapid dystrophic nail and hair growth changes.

Physical Examination & Provocative Maneuvers

Physical examination must map sensory boundaries and quantify hypersensitivity using standardized bedside maneuvers:

• Hoffmann-Tinel Sign: Light percussion directly over the suspected neuroma or site of nerve entrapment -> Elicits distal electric shock-like paresthesias radiating along the anatomical distribution of the injured nerve [Sensitivity 68%, Specificity 88%].
• Dynamic Mechanical Allodynia: Light stroking of the skin with a cotton wisp or soft brush at 1 to 2 cm/s -> Evokes sharp, burning distress in an area extending beyond the immediate site of injury [Sensitivity 82%, Specificity 86%].
• Static Mechanical Allodynia: Application of calibrated von Frey monofilaments (or blunt pressure) to skin outside the primary nerve territory -> Elicits pain at force levels below standard sensory threshold (<15 g) [Sensitivity 76%, Specificity 84%].
• Pinprick Hyperalgesia: Application of a blunt neurological pin or 40-g weighted needle -> Elicits exaggerated, prolonged stinging pain and after-sensations [Sensitivity 84%, Specificity 80%].
• Selective Local Anesthetic Diagnostic Infiltration: Ultrasound-guided targeted infiltration of 1 to 2 mL of 1% lidocaine precisely around the focal neuroma or entrapped nerve -> Complete abolition (≥80% VAS reduction) of spontaneous pain and mechanical allodynia confirms a peripheral generator driving the syndrome [Sensitivity 94%, Specificity 91%].

6. Imaging and Diagnostic Studies

The diagnostic algorithm relies on autonomic differentiation procedures to confirm sympathetic independence, followed by high-resolution neuroimaging and electrodiagnostic testing.

Autonomic Differentiation Protocols (Gold Standard)

• Diagnostic Sympathetic Ganglion Blockade: Performed via fluoroscopic or ultrasound guidance using 5 to 8 mL of 0.25% bupivacaine at the stellate ganglion (C6/C7 for upper extremity) or lumbar sympathetic chain (L2 to L4 anterolateral vertebral body for lower extremity).
  Verification Criteria: Confirmed sympathetic denervation requires documented Horner syndrome (upper extremity: ptosis, miosis, facial anhidrosis), a recorded skin temperature elevation of ≥1.5°C to 2.0°C by thermocouple probe in the distal extremity, and loss of the sympathogalvanic reflex.
  Interpretation: If verified sympathetic denervation achieves <30% reduction in visual analog scale (VAS) pain scores, the condition is definitively confirmed as Non-Sympathetically Maintained Pain (SIP).
• Systemic Phentolamine Infusion Test: Intravenous infusion of phentolamine mesylate (0.5 to 1.0 mg/kg infused over 20 to 30 minutes with continuous ECG and blood pressure monitoring), preceded or followed by blind saline placebo. Patients with pure SIP demonstrate zero analgesic response to alpha-adrenergic antagonism, establishing absolute autonomic independence.

Neuroimaging & Electrodiagnostic Studies

• High-Resolution Neuromuscular Ultrasound (HRUS): High-frequency linear probes (15 to 22 MHz) provide real-time visualization of nerve continuity, cross-sectional area (CSA) enlargement, loss of normal fascicular architecture, and end-bulb neuroma formation. Color Doppler demonstrates hypervascularity within active neuromas.
• Magnetic Resonance Neurography (MRN): 3-Tesla fat-suppressed T2-weighted, STIR, and diffusion tensor imaging (DTI) sequences visualize intraneural hyperintensity, focal caliber transition, perineural fibrosis, and distal denervation changes in target musculature (edema pattern early, fatty infiltration late).
• Electromyography and Nerve Conduction Studies (EMG/NCS): Identifies large-fiber axonotmesis, focal demyelinating conduction block, and chronicity of denervation (fibrillation potentials, positive sharp waves). Note that normal electrodiagnostic testing does not exclude small-fiber neuropathies or isolated cutaneous neuromas.
• Quantitative Sensory Testing (QST): Standardized protocol (German Research Network on Neuropathic Pain, DFNS) assessing thermal detection (cold/warm), thermal pain, mechanical detection, and mechanical pain thresholds, profiling sensory loss versus hyperalgesia phenotypes.

7. Classification

Classifying non-sympathetically maintained pain requires defining the anatomical origin of the neural lesion and delineating its autonomic responsiveness:

8. Treatment

Management of non-sympathetically maintained pain requires a multimodal approach combining evidence-based pharmacotherapy, graded sensorimotor rehabilitation, and reconstructive microsurgery.

Medical and Nonoperative Therapy

Systemic pharmacotherapy follows international NeuPSIG consensus guidelines for peripheral neuropathic pain:

• First-Line Systemic Agents:
  Gabapentinoids: Gabapentin (titrated to 900–3600 mg/day in three divided doses) or Pregabalin (150–600 mg/day in two divided doses). Mechanism: Bind the alpha-2-delta auxiliary subunit of presynaptic voltage-gated calcium channels, attenuating excitatory neurotransmitter release in the dorsal horn.
  Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Duloxetine (60–120 mg once daily) or Venlafaxine (150–225 mg once daily). Mechanism: Potentiate descending noradrenergic and serotonergic inhibitory pain pathways.
  Tricyclic Antidepressants (TCAs): Nortriptyline or Amitriptyline (25–100 mg at bedtime). Mechanism: Inhibit serotonin/norepinephrine reuptake, block voltage-gated sodium channels, and antagonize NMDA receptors.
• Second-Line Topical Formulations:
  5% Lidocaine Patches: Applied over focal allodynic skin (12 hours on, 12 hours off) to attenuate local ectopic sodium channel discharges.
  8% Capsaicin High-Concentration Topical Patch: Single 60-minute application under local anesthesia; induces reversible defunctionalization and retraction of hyperactive epidermal nociceptive C-fiber terminals via massive TRPV1 activation.
• Sensorimotor Rehabilitation: Graded motor imagery (GMI), formal mirror visual feedback therapy, and tactile desensitization protocols with graded textures (silk, cotton, terrycloth, rough velcro) restore altered somatosensory cortical representation.

Operative Interventions

Surgical goals include eradicating mechanical compression, re-establishing neural continuity, or providing physiologic receptor end-organs for regenerating axons:

• Decompression and External Neurolysis: Indicated for chronic entrapment without frank axonal disruption. Thorough longitudinal release of overlying fascial retinacula, complete excision of constricting scar bands, and transposition to a healthy, vascularized, unscarred bed.
• Targeted Muscle Reinnervation (TMR): Modern gold standard for symptomatic terminal neuromas. The pathologic neuroma is sharply excised under microscopic magnification back to healthy, non-fibrotic fascicular architecture showing brisk punctate bleeding. The proximal sensory or mixed nerve stump is coapted end-to-end to a redundant motor nerve branch entering an adjacent target muscle using 8-0 or 9-0 nylon epineurial sutures. Regenerating axons systematically reinnervate denervated motor endplates, abolishing disordered axonal sprouting and permanently preventing neuroma recurrence.
• Regenerative Peripheral Nerve Interface (RPNI): The trimmed nerve stump is implanted into a free autologous devascularized skeletal muscle graft (approximately 3 x 1.5 x 0.5 cm) harvested from adjacent muscle. The muscle graft acts as an isolated biological sink, undergoing revascularization and neurotization, terminating chaotic axonal regeneration.
• Deep Intramuscular / Intramedullary Transposition: Sharp neuroma excision followed by embedding the proximal nerve end deep within adjacent unscarred muscle belly or drilling an oblique drill hole into cortical bone for intramedullary transposition. Note: TMR and RPNI demonstrate superior long-term outcome metrics compared to simple transposition.
• Neuromodulation:
  Dorsal Root Ganglion (DRG) Stimulation: Leads placed within the intervertebral neural foramen directly adjacent to the target DRG provide superior electrical capture and selective paresthesia coverage for distal focal pain syndromes (hand, foot, knee, groin) compared to traditional dorsal column leads.
  Spinal Cord Stimulation (SCS): High-frequency (10 kHz) or burst stimulation applied to the dorsal columns for broad regional radiculopathies failing surgical release.

Indications & Contraindications

Surgical intervention is strictly indicated under objective criteria and contraindicated in specific physiological profiles:

• Explicit Surgical Indications:
  1. Severe localized neuropathic pain with a well-defined focal Tinel sign coinciding with an identifiable nerve stump or entrapment site.
  2. Documented ≥80% temporary relief of spontaneous pain and allodynia following selective local anesthetic infiltration around the suspected generator.
  3. Failure of ≥3 to 6 months of comprehensive nonoperative multimodal therapy (gabapentinoids, SNRIs, graded physical therapy).
  4. High-resolution ultrasound or MRN confirmation of focal neuroma formation or compressive architectural deformation.
• Explicit Contraindications:
  1. Surgical or Chemical Sympathectomy: Absolutely contraindicated in confirmed SIP. Sympathectomy carries zero therapeutic efficacy in non-sympathetically maintained conditions and exposes the patient to severe post-sympathectomy deafferentation neuralgia.
  2. Active systemic infection or compromised soft tissue envelope directly overlying the proposed surgical site.
  3. Unmanaged primary central nociplastic pain (e.g., fibromyalgia) lacking an identifiable peripheral nerve generator.

9. Outcome

Patient-reported outcome measures (PROMs) quantify functional restoration and pain reduction in non-sympathetically maintained syndromes:

• Validated Clinical Assessment Instruments: Neuropathic pain severity and functional interference are evaluated using the Visual Analog Scale (VAS) or Numeric Rating Scale (NRS), the Neuropathic Pain Symptom Inventory (NPSI), the Brief Pain Inventory (BPI), and the Disabilities of the Arm, Shoulder, and Hand (DASH) or QuickDASH scores.
• Targeted Muscle Reinnervation Outcomes: Prospective multi-center clinical trials demonstrate that TMR achieves a >70% to 80% reduction in residual limb pain and phantom limb pain compared to traditional traction neurectomy. In major amputees undergoing primary prophylactic TMR at the time of amputation, symptomatic neuroma formation drops from historical rates of 25% to under 4%.
• Regenerative Peripheral Nerve Interface Outcomes: Long-term follow-up demonstrates statistically significant reductions in neuroma pain scores (mean reduction of 4.2 points on a 10-point NRS) with over 80% of patients successfully wearing lower extremity prostheses without pain limitation.
• DRG Stimulation Outcomes: Multicenter prospective randomized trials (ACCURATE study) showed an 81.2% treatment success rate (≥50% pain reduction) for DRG stimulation in focal lower extremity neuropathic pain, significantly outperforming traditional dorsal column spinal cord stimulation (55.7%).

10. Complications

Complications associated with non-sympathetically maintained pain syndromes and their surgical remediation must be anticipated across distinct postoperative phases:

11. Pearls and Pitfalls

Experienced peripheral nerve surgeons and pain specialists employ specific technical principles to maximize diagnostic certainty and avoid devastating management errors:

• Diagnostic Blockade Protocol (Pearl): Never accept a clinical diagnosis of sympathetically maintained pain or proceed to sympathectomy without documenting objective physiologic endpoints during sympathetic blockade (temperature rise ≥1.5°C, complete Horner syndrome, and sympathogalvanic reflex abolition). A failure to obtain ≥50% relief under verified sympathetic denervation definitively confirms SIP.
• Local Infiltration Confirmation (Pearl): Perform an ultrasound-guided selective diagnostic block using 1.0 mL of 1% plain lidocaine directly around the identified neuroma. A transient >80% reduction in spontaneous and evoked pain proves that a surgically addressable peripheral generator drives the clinical syndrome.
• TMR Tension-Free Coaptation (Pearl): During Targeted Muscle Reinnervation, match the donor and recipient nerve diameters closely. Use an operative microscope, perform clean perpendicular cuts without crush injury, and place two to three interrupted 8-0 or 9-0 nylon epineurial sutures completely without tension.
• The Sympathectomy Trap (Pitfall): Performing surgical or chemical sympathectomy in a patient with sympathetically independent pain is a severe clinical error. It confers zero pain relief while subjecting the patient to irreversible compensatory hyperhidrosis, severe postsympathectomy neuralgia, and surgical morbidity.
• The Traction Neurectomy Error (Pitfall): Do not simply apply traction to a cut nerve, transect it with scissors, and allow it to snap back into the wound bed. This historical technique results in a recurrent terminal neuroma located 2 to 3 cm proximal, often adherent to deeper fascial planes with worse neuropathic pain.

12. Controversy

Several fundamental controversies persist regarding the neurobiological evolution and therapeutic management of non-sympathetically maintained pain syndromes:

Temporal Transition from SMP to SIP in Chronic CRPS

A longstanding debate surrounds the temporal evolution of Complex Regional Pain Syndrome. In the acute phase (0 to 6 months), a substantial proportion of CRPS patients exhibit sympathetically maintained pain responsive to adrenergic blockade. However, longitudinal clinical investigations demonstrate that with chronicity (>12 to 24 months), the sympathetic component frequently extinguishes, transitioning into a pure sympathetically independent state driven by irreversible spinal dorsal horn disinhibition, microglial activation, and thalamocortical reorganization. This transition explains why delayed sympathetic nerve blocks or surgical sympathectomy uniformly fail in chronic, long-standing CRPS.

DRG Stimulation versus Dorsal Column Spinal Cord Stimulation

While traditional dorsal column spinal cord stimulation (SCS) has served as the historical standard for refractory extremity neuropathies, capturing isolated distal dermatomes (e.g., the foot, ankle, or palmar hand) remains challenging due to the thick dorsal cerebrospinal fluid (CSF) layer and postural positional lead shifts. Dorsal Root Ganglion (DRG) stimulation places electrode leads directly into the intervertebral neural foramen where there is minimal CSF buffer, delivering targeted electric fields directly to the primary sensory cell bodies. High-level comparative trials indicate superior efficacy for DRG stimulation in focal SIP entities, though debate continues regarding long-term lead migration rates and procedural complexity.

Primary Prophylactic TMR vs Secondary Delayed Revision

Emerging microsurgical evidence strongly advocates for performing primary prophylactic Targeted Muscle Reinnervation or RPNI concurrently at the index amputation or major nerve sacrifice procedure. Proponents demonstrate that prophylactic coaptation dramatically suppresses neuroma formation and phantom limb pain. Skeptics argue that routine primary TMR prolongs operative duration in trauma or critically ill vascular patients and that a subset of patients would never develop symptomatic neuromas. Ongoing multicenter randomized trials are defining the risk-benefit thresholds for universal primary nerve coaptation.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Roberts WJ. A hypothesis on the physiological basis for causalgia and related pains. Pain. 1986. doi:10.1016/0304-3959(86)90116-8 [Level IV: Seminal Mechanistic / Conceptual Framework]
• Raja SN, Treede RD, Davis KD et al. Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiology. 1991. doi:10.1097/00000542-199104000-00012 [Level I: Placebo-Controlled Diagnostic Trial]
• Harden RN, Bruehl S, Perez RS et al. Validation of proposed diagnostic criteria (the ‘Budapest Criteria’) for Complex Regional Pain Syndrome. Pain. 2010. doi:10.1016/j.pain.2010.04.030 [Level II: Prospective Multicenter Validation Study]
• Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010. doi:10.1016/S1474-4422(10)70143-5 [Level IV: Translational Phenotype & Mechanism Analysis]
• Finnerup NB, Attal N, Haroutounian S et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015. doi:10.1016/S1474-4422(14)70251-0 [Level I: Systematic Review & Meta-Analysis]

15. Master Class Pro-Tip

When evaluating a patient with refractory limb pain following trauma or surgery, never assume the syndrome is sympathetically maintained simply because the extremity feels cool or appears mottled. Temperature asymmetry often reflects disuse-mediated down-regulation of cutaneous circulation or localized edema rather than active adrenergic vasoconstriction. Always perform an ultrasound-guided selective diagnostic block with 1 mL of 1% lidocaine directly at the site of maximal Tinel tenderness before considering invasive neuromodulation or sympathectomy. If local anesthetic at the focal neuroma completely abolishes the radiating pain and static allodynia, you have definitively unmasked a surgically treatable peripheral generator. Proceed with microsurgical exploration and reconstructive axonal termination via Targeted Muscle Reinnervation or RPNI rather than chasing autonomic pathways that play no role in sustaining the disorder.

Master Class Surgical Pearl: Peripheral Neuropathic Architecture & Autonomic Differentiation